Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: IRWIN JAMES FRANKEL who wrote (3412)	7/5/1999 10:49:00 AM
From: BDR	Read Replies (1) of 10280

<Cut back on R&D expenses - Bad.> Ceteris paribus, as economists like to say, reduced losses would be nice. But if the reduced expenses are achieved by reducing R&D then we may be in trouble. I am not sure of all the causes for the recent price gyrations but it appears that the revenue streams anticipated for some of the drugs in the pipeline have slipped a year or two further into the future. I would happily live with increased R&D if it meant pulling some of that revenue forward in time. That would do more for the value of the stock than fluctuations in quarterly earnings(losses).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next